ֱ

Meeting Coverage

NACLC

North America Conference on Lung Cancer

CDK4/6 Inhibitor in SCLC Cuts Chemo-Induced Myelosuppression

Reduced severe neutropenia and less need for supportive care with trilaciclib

NACLC over a computer rendering of lung cancer

Latest NACLC Meeting Coverage

Dual Checkpoint Blockade With Some Chemo Boosts OS in NSCLC

Nivolumab-ipilimumab with two cycles of chemotherapy improved survival, regardless of histology or PD-L1 status

October 17, 2020

Latest Oncology/Hematology Meeting Coverage